Vancouver, British Columbia, March 8th, 2017 - LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX-V: LMD) is pleased to announce the issuance on Feb 28th, 2017 of a US patent to its recently acquired subsidiary, Apteryx, Inc. ("Apteryx") entitled "System and Method for Dentition Specific Image Enhancement" (patent no. 9579073). The patent discloses systems and methods for automatically generating x-ray image acquisition and processing settings that apply specifically to the type of patient and dental structure being examined.
When acquiring high-quality radiographic images of teeth and related anatomy, dental practitioners must decide on a number of settings and parameters that relate not only to the image acquisition but also to post-processing. Appropriate setting of these parameters is critical in generating a final image upon which sound diagnostic decisions can be made. The optimal settings are affected by the type of structure(s) being imaged - e.g. tooth, restorative material, bone, root canal etc. - and also by the characteristics of the patient - e.g. gender, weight, age etc. This new patent claims both systems and methods for automating this process: the claimed systems and methods accept as input at least one characteristic of the dentition and at least one characteristic of the patient and automatically generate both recommended x-ray image acquisition settings as well as corresponding image processing parameters.
"I believe this invention will be a major benefit to oral health care practitioners, providing them with valuable decision support to assist them in acquiring high-quality dental radiographs on a consistent basis, which is essential for optimal diagnosis and clinical decisions for patients," said inventor and Apteryx founder, Kevin Crucs.
Dr. Dave Gane, LED CEO, remarked, "It has been estimated that up to 50% of dental radiographs are of a poor standard. Easy-to-use, automated systems that provide guidance to clinicians in selecting appropriate image acquisition and processing settings are extremely welcome and could have widespread utility." Dr. Gane continued, "This patent adds to Apteryx's growing and already impressive intellectual property portfolio in the imaging software arena."
With this latest addition to the portfolio, Apteryx now has 23 patents issued by the US Patent and Trademark Office (USPTO) and 41 patents world-wide.
About LED Medical Diagnostics
Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd and Apteryx, Inc. provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQX under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.
Apteryx Inc., a wholly owned subsidiary of LED Medical Diagnostics Inc., is a software development company that creates and develops software applications and systems that are leading products in their respective industry segments. The company exceeds the expectations of its customers by creating timely, innovative and cost effective software solutions that improve the profitability of the clients businesses. Apteryx is a software development company Apteryx has distributed over 200,000 licenses of its industry leading software packages, such as XrayVision, XrayVision DCV and XVWeb. Current products include OEM imaging applications and extensions for large domestic and international dental companies, Apteryx-branded applications sold through value-added reseller networks and via the company's Web site, source code libraries and other custom applications. The company's products are written in any of a number of programming languages depending upon the needs of the project.
Phone: 905.326.1888, ext. 10
David Gane, CEO
Phone: 604-434-4614 x227
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.